H2H data updated: 2026-07-18 01:16 UTC
Brandon Nakashima vs Marcos Giron H2H: 2-1
Brandon Nakashima holds a 2–1 lead over Marcos Giron in their ATP head-to-head. Across 3 main-draw meetings, Brandon Nakashima leads 2–1 on hard courts. Most recently, Marcos Giron won the 2025 Vanda Pharmaceuticals Hellenic Championship fourth round 7-6(7) 6-1.
Want to explore more matchups? Advanced rivalry search lets you browse current and historical rivalries, unbeaten records, or every matchup for a player.
United States
Age 24
Right-Handed
188 cm / 6'2"
H2H
2
–
1
3 main draw meetings
United States
Age 32
Right-Handed
180 cm / 5'11"
H2H Match Log
| Date | Tournament | Category | Round | Surface | Winner | Score | Loser | Match |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2025* | Vanda Pharmaceuticals Hellenic Championship | ATP 250 | R16 | Hard | Marcos Giron | 7-6(7) 6-1 | Brandon Nakashima | Match data |
| Sep 22, 2025* | Chengdu Open | ATP 250 | QF | Hard | Brandon Nakashima | 6-3 2-6 7-6 | Marcos Giron | Match data |
| Sep 25, 2022* | San Diego | ATP 250 | F | Hard | Brandon Nakashima | 6-4 6-4 | Marcos Giron | Match data |
* Estimated match date where the exact historical date is unavailable.
Career Comparison
| Player | Current | Peak | Pts | Elo | W | L | Win % | GS | 1000 | Finals | 500 | 250 | Titles |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brandon Nakashima | #32 | #29 | 1,700 | 1,921 | 138 | 121 | 53.3% | 0 | 0 | 0 | 0 | 1 | 1 |
| Marcos Giron | #87 | #37 | 1,265 | 1,916 | 137 | 160 | 46.1% | 0 | 0 | 0 | 0 | 1 | 1 |
Career Progression by Age
Seasons are aligned by the age each player spent most of that calendar year. GS and Titles are cumulative career totals through that season.
| Age | Brandon Nakashima | Marcos Giron | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yr | W-L | Win % | Rank | Elo | GS | Titles | Yr | W-L | Win % | Rank | Elo | GS | Titles | |
| 18 | 2020 | 3–2 | 60.0% | #166 | 1,547 | 0 | 0 | — | — | — | — | — | — | — |
| 19 | 2021 | 15–10 | 60.0% | #68 | 1,800 | 0 | 0 | — | — | — | — | — | — | — |
| 20 | 2022 | 30–23 | 56.6% | #47 | 1,860 | 0 | 1 | 2014 | 0–2 | 0.0% | #375 | 1,479 | 0 | 0 |
| 21 | 2023 | 13–20 | 39.4% | #134 | 1,684 | 0 | 1 | — | — | — | — | — | — | — |
| 22 | 2024 | 25–23 | 52.1% | #38 | 1,818 | 0 | 1 | — | — | — | — | — | — | — |
| 23 | 2025 | 33–29 | 53.2% | #35 | 1,780 | 0 | 1 | — | — | — | — | — | — | — |
| 24 | 2026 | 19–14 | 57.6% | #32 | 1,792 | 0 | 1 | 2018 | 1–1 | 50.0% | #308 | 1,503 | 0 | 0 |
| 25 | — | — | — | — | — | — | — | 2019 | 2–4 | 33.3% | #102 | 1,597 | 0 | 0 |
| 26 | — | — | — | — | — | — | — | 2020 | 9–9 | 50.0% | #73 | 1,775 | 0 | 0 |
| 27 | — | — | — | — | — | — | — | 2021 | 22–19 | 53.7% | #66 | 1,857 | 0 | 0 |
| 28 | — | — | — | — | — | — | — | 2022 | 18–28 | 39.1% | #61 | 1,778 | 0 | 0 |
| 29 | — | — | — | — | — | — | — | 2023 | 24–29 | 45.3% | #60 | 1,790 | 0 | 0 |
| 30 | — | — | — | — | — | — | — | 2024 | 27–25 | 51.9% | #46 | 1,845 | 0 | 1 |
| 31 | — | — | — | — | — | — | — | 2025 | 23–28 | 45.1% | #65 | 1,722 | 0 | 1 |
| 32 | — | — | — | — | — | — | — | 2026 | 11–15 | 42.3% | #87 | 1,700 | 0 | 1 |